These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 39034866)
1. Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues. Fang Z; Raza U; Song J; Lu J; Yao S; Liu X; Zhang W; Li S ESC Heart Fail; 2024 Jul; ():. PubMed ID: 39034866 [TBL] [Abstract][Full Text] [Related]
2. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. Paulus WJ; Tschöpe C J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677 [TBL] [Abstract][Full Text] [Related]
4. Asymptomatic Diabetic Cardiomyopathy: an Underrecognized Entity in Type 2 Diabetes. Stanton AM; Vaduganathan M; Chang LS; Turchin A; Januzzi JL; Aroda VR Curr Diab Rep; 2021 Sep; 21(10):41. PubMed ID: 34580767 [TBL] [Abstract][Full Text] [Related]
5. The ubiquitin ligase WWP1 contributes to shifts in matrix proteolytic profiles and a myocardial aging phenotype with diastolic heart. Matesic LE; Freeburg LA; Snyder LB; Duncan LA; Moore A; Perreault PE; Zellars KN; Goldsmith EC; Spinale FG Am J Physiol Heart Circ Physiol; 2020 Oct; 319(4):H765-H774. PubMed ID: 32822210 [TBL] [Abstract][Full Text] [Related]
6. Emerging Role of Adipocyte Dysfunction in Inducing Heart Failure Among Obese Patients With Prediabetes and Known Diabetes Mellitus. Berezin AE; Berezin AA; Lichtenauer M Front Cardiovasc Med; 2020; 7():583175. PubMed ID: 33240938 [TBL] [Abstract][Full Text] [Related]
7. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases. Lagoumtzi SM; Chondrogianni N Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756 [TBL] [Abstract][Full Text] [Related]
8. Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap. Shah SJ; Kitzman DW; Borlaug BA; van Heerebeek L; Zile MR; Kass DA; Paulus WJ Circulation; 2016 Jul; 134(1):73-90. PubMed ID: 27358439 [TBL] [Abstract][Full Text] [Related]
9. Sodium-glucose cotransporter 2 inhibitors represent a paradigm shift in the prevention of heart failure in type 2 diabetes patients. Kashiwagi A; Araki S; Maegawa H J Diabetes Investig; 2021 Jan; 12(1):6-20. PubMed ID: 32563214 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms contributing to cardiac remodelling. Wu QQ; Xiao Y; Yuan Y; Ma ZG; Liao HH; Liu C; Zhu JX; Yang Z; Deng W; Tang QZ Clin Sci (Lond); 2017 Sep; 131(18):2319-2345. PubMed ID: 28842527 [TBL] [Abstract][Full Text] [Related]
11. Possibility of a New Therapeutic Strategy for Left Ventricular Dysfunction in Type 2 Diabetes. Sakamoto M; Matsutani D; Kayama Y J Clin Med Res; 2018 Nov; 10(11):799-805. PubMed ID: 30344814 [TBL] [Abstract][Full Text] [Related]
12. Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis/Stiffness in Nondiabetic Heart Failure: A Multimodality Study. Santos-Gallego CG; Requena-Ibanez JA; San Antonio R; Garcia-Ropero A; Ishikawa K; Watanabe S; Picatoste B; Vargas-Delgado AP; Flores-Umanzor EJ; Sanz J; Fuster V; Badimon JJ JACC Cardiovasc Imaging; 2021 Feb; 14(2):393-407. PubMed ID: 33129742 [TBL] [Abstract][Full Text] [Related]
13. Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure. Garcia AG; Wilson RM; Heo J; Murthy NR; Baid S; Ouchi N; Sam F Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H587-96. PubMed ID: 22730392 [TBL] [Abstract][Full Text] [Related]
14. Metabolism and Chronic Inflammation: The Links Between Chronic Heart Failure and Comorbidities. Li Z; Zhao H; Wang J Front Cardiovasc Med; 2021; 8():650278. PubMed ID: 34026868 [TBL] [Abstract][Full Text] [Related]
15. Ablation of cardiac TIGAR preserves myocardial energetics and cardiac function in the pressure overload heart failure model. Okawa Y; Hoshino A; Ariyoshi M; Kaimoto S; Tateishi S; Ono K; Uchihashi M; Iwai-Kanai E; Matoba S Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1366-H1377. PubMed ID: 30901275 [TBL] [Abstract][Full Text] [Related]
16. The cardiac structure-function relationship and the renin-angiotensin-aldosterone system in hypertension and heart failure. Brilla CG Curr Opin Cardiol; 1994 Jul; 9 Suppl 1():S2-10; discussion S10-1. PubMed ID: 7827369 [TBL] [Abstract][Full Text] [Related]
17. Accelerated ageing and coronary microvascular dysfunction in chronic heart failure in Tgαq*44 mice. Berkowicz P; Totoń-Żurańska J; Kwiatkowski G; Jasztal A; Csípő T; Kus K; Tyrankiewicz U; Orzyłowska A; Wołkow P; Tóth A; Chlopicki S Geroscience; 2023 Jun; 45(3):1619-1648. PubMed ID: 36692592 [TBL] [Abstract][Full Text] [Related]
18. The role of tissue Renin-Angiotensin-aldosterone system in the development of endothelial dysfunction and arterial stiffness. Aroor AR; Demarco VG; Jia G; Sun Z; Nistala R; Meininger GA; Sowers JR Front Endocrinol (Lausanne); 2013 Oct; 4():161. PubMed ID: 24194732 [TBL] [Abstract][Full Text] [Related]
19. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496 [TBL] [Abstract][Full Text] [Related]
20. Pro-Senescence and Anti-Senescence Mechanisms of Cardiovascular Aging: Cardiac MicroRNA Regulation of Longevity Drug-Induced Autophagy. Pulakat L; Chen HH Front Pharmacol; 2020; 11():774. PubMed ID: 32528294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]